Results 131 to 140 of about 8,376 (205)

Development of a protease-resistant ADAMTS13 to improve stability against proteolytic degradation. [PDF]

open access: yesBlood Adv
DeYoung V   +6 more
europepmc   +1 more source

Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease. [PDF]

open access: yesRes Pract Thromb Haemost
El Otmani H   +6 more
europepmc   +1 more source

Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease: A Case-Control Study. [PDF]

open access: yesInt J Mol Sci
Mavrikou I   +16 more
europepmc   +1 more source

Successful Treatment of refractory Thrombotic Thrombocytopenic Purpura With The Monoclonal Antibody Rituximab :A case Report [PDF]

open access: yes
Much of thrombotic thrombocytopenic purpura (TTP) is attributed to the presence of an autoantibody to ADAMTS-13, the metalloprotease that degrades ultralarge von Willebrand protein multimers.
فتحی, افشین   +1 more
core  

Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcome. [PDF]

open access: yesLupus Sci Med
Weisinger J   +17 more
europepmc   +1 more source

Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTP. [PDF]

open access: yesAm J Hematol
Robert M   +29 more
europepmc   +1 more source

Challenges in diagnosing thrombotic thrombocytopenic purpura. [PDF]

open access: yesHematol Transfus Cell Ther
Jacobs JW, Booth GS, Adkins BD.
europepmc   +1 more source

Is COVID-19 Coagulopathy a Thrombotic Microangiopathy? A Prospective, Observational Study. [PDF]

open access: yesInt J Mol Sci
Silingardi M   +14 more
europepmc   +1 more source

Immune-coagulation dynamics in severe COVID-19 revealed by autoantibody profiling and multi-omics integration. [PDF]

open access: yesSci Rep
Ambikan AT   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy